| Literature DB >> 22649680 |
A V Safonova1, A N Petrin, S D Arutyunov, V N Tsarev, L A Akulenko, A O Zorina, D V Rebrikov, A V Rubanovich, S A Borinskaya, N K Yankovsky.
Abstract
Gingivitis and periodontitis are chronic inflammatory diseases of the periodontal tissue in humans caused by both environmental and genetic factors. The human cytokine genes that regulate the immune response may play an important role in the development of these chronic inflammatory diseases. The aim of this study is to analyze the allele status of eight human cytokine genes and to associate it with the inflammation of periodontal tissue in humans. A total of 296 unrelated males of Russian origin were studied. A significant association of theIL1BandIL6 minor alleles and gingivitis was found. In addition, we found a significant association of the OHI-S index with theIL18gene alleles. The influence of genetic factors on gingivitis may contribute to the understanding of the mechanisms of interaction between genetic and environmental factors in periodontal conditions, and to the identification of risk groups for effective prevention and treatment.Entities:
Keywords: cytokine genes; genetic polymorphism; gingivitis; periodontitis
Year: 2011 PMID: 22649680 PMCID: PMC3347598
Source DB: PubMed Journal: Acta Naturae ISSN: 2075-8251 Impact factor: 1.845
Fig. 3Distribution of the total number of minor alleles copies found in the SNP IL1B (-511) and IL6 (-174) SNPs vs. severity of gingivitis. The group of individuals with PMA index ≥ 30 (moderate and severe gingivitis) includes 87 individuals. The group of individuals with PMA index < 30 (no gingivitis and mild gingivitis) includes 197 individuals.
SNPs of cytokine genes checked in this work
| Gene | Chromosome | SNP | dbSNP ID | Function | Ref. |
| 12q14 | +874 Т>A | rs2430561 | Increasing the expression of HLA II by antigen-representing cells, increasing the level of intercellular adhesion molecules, increasing the level of proliferation of T-cells and production of Th1-cytokines |
[ | |
| 2q14 | -889 C>T | rs1800587 | Anti-inflammation cytokine. Activation of osteoclasts, T-cells, and matrix metal proteases |
[ | |
| 2q14 | -511 G>A | rs16944 | |||
| 5q31.1 | -590 C>T | rs2243250 | Decreasing the level of anti-inflammation cytokine. Involvement in differentiation of B-cells and production of antibodies |
[ | |
| 7p21 | -174 G>C | rs1800795 | Activation of osteoclasts. Involvement in differentiation of B-cells and production of antibodies |
[ | |
| 1q31-q32 | -592 C>A | rs1800872 | Inhibiting replication of T-cells and inhibiting synthesis of anti-inflammation cytokine. Involvement in differentiation of B-cells and production of antibodies |
[ | |
| 11q22.2-q22.3 | -607 G/T | rs1946518 | Anti-inflammation cytokine. Increasing the level of producing IFN-γ by Т-cells. |
[ | |
| 6p21.3 | -308 G>A | rs1800629 | Activation of osteoclasts and matrix metal proteases. Increasing the expression of HLA II by antigen-representing cells. Increasing the level of intercellular adhesion molecules |
[ |
Mean values of the dental indices in carriers of some genotypes over eight cytokine genes
| Genotype | N | Dental indices (±SE)* | Minor allele effect** | |||
| PMA | PPD | OHI-S | ||||
| A/A | 67 | 0.25±0.02 | 1.61±0.10 | 1.85±0.09 | ||
| T/A | 127 | 0.22±0.01 | 1.42±0.06 | 1.74±0.07 | ||
| T/T | 87 | 0.24±0.04 | 1.48±0.07 | 1.78±0.07 | ||
| C/C | 140 | 0.22±0.01 | 1.40±0.06 | 1.72±0.06 |
PMA↓ Recessive | |
| C/T | 118 | 0.26±0.02 | 1.59±0.07 | 1.84±0.07 | ||
| T/T | 27 | 0.20±0.02 | 1.45±0.11 | 1.79±0.12 | ||
| A/A | 29 | 0.26±0.03 | 1.41±0.11 | 1.77±0.12 |
PMA↑ Recessive | |
| G/A | 122 | 0.23±0.02 | 1.44±0.07 | 1.80±0.07 | ||
| G/G | 133 | 0.22±0.01 | 1.49±0.06 | 1.76±0.06 | ||
| C/C | 171 | 0.24±0.01 | 1.49±0.06 | 1.79±0.05 | ||
| C/T | 98 | 0.23±0.02 | 1.45±0.07 | 1.78±0.07 | ||
| T/T | 14 | 0.19±0.04 | 1.51±0.22 | 1.57±0.20 | ||
| C/C | 61 | 0.25±0.02 | 1.53±0.10 | 1.70±0.07 |
PMA↑ Dominant | |
| G/C | 139 | 0.24±0.01 | 1.48±0.06 | 1.83±0.07 | ||
| G/G | 85 | 0.21±0.02 | 1.46±0.08 | 1.74±0.08 | ||
| A/A | 23 | 0.24±0.03 | 1.57±0.15 | 1.66±0.16 |
OHI-S↓ Dominant | |
| C/A | 110 | 0.22±0.01 | 1.46±0.07 | 1.72±0.06 | ||
| C/C | 152 | 0.24±0.01 | 1.49±0.06 | 1.84±0.06 | ||
| C/C | 85 | 0.25±0.02 | 1.50±0.08 | 1.69±0.07 |
OHI-S↑ Recessive | |
| A/C | 140 | 0.21±0.01 | 1.44±0.06 | 1.75±0.06 | ||
| A/A | 57 | 0.27±0.02 | 1.57±0.09 | 1.96±0.09 | ||
| A/A | 4 | 0.17±0.04 | 1.45±0.22 | 1.83±0.25 | ||
| G/A | 68 | 0.25±0.02 | 1.50±0.08 | 1.84±0.09 | ||
| G/G | 212 | 0.23±0.03 | 1.48±0.05 | 1.76±0.05 | ||
*The association level is significant.
**The arrow indicates an increased or decreased value of the character for the minor allele carriers (dominant effect) and for homozygous minor allele carriers (recessive effect). The minimum levels of significance are calculated in accordance with the permutation test.